{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:12:52Z","timestamp":1773389572671,"version":"3.50.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To systematically describe the clinical characteristics of tuberculosis (TB) complicated by hemophagocytic lymphohistiocytosis (HLH), with the aim of informing early diagnosis, precise classification, and therapeutic decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 19 hospitalized patients diagnosed with TB-HLH between January 2020 and December 2025 were consecutively enrolled. Based on the presence of disseminated TB, patients were divided into a disseminated group (n = 10) and a non-disseminated group (n = 9). Demographic data, clinical symptoms, laboratory parameters, imaging findings, treatment regimens, and clinical outcomes were systematically collected and compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No statistically significant differences were observed in baseline characteristics such as age and gender between the two groups (P &amp;gt; 0.05). Common clinical symptoms included fever, fatigue, weight loss, and hepatosplenomegaly. Central nervous system symptoms (e.g., headache, impaired consciousness) were observed only in the disseminated group (4 cases vs. 0 case, P\u00a0=\u00a00.033). The disseminated group had significantly lower serum C-reactive protein (CRP) levels compared to the non-disseminated group (73.20 \u00b1 42.38 mg\/L vs. 125.41 \u00b1 61.45 mg\/L, P\u00a0=\u00a00.044). Eighteen patients received anti-tuberculosis therapy, one patient with AIDS discontinued treatment due to critical illness. Glucocorticoids were administered to 16 patients as adjunct therapy for HLH. Among the three patients who did not receive steroids, one had a short disease course and mild bone marrow suppression, one presented with concurrent acute hepatic and renal failure, and one exhibited hematologic and symptomatic improvement following after anti-TB treatment. The overall mortality rate was 21.1% (4\/19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that central nervous system symptoms serve as a critical indicator for disseminated TB complicated by HLH. The inflammatory profile in TB-HLH exhibits unique features, such as relatively lower CRP in disseminated cases. Clinical management requires a combination of effective anti-TB therapy and a stratified immunomodulatory strategy based on the severity of the hyperinflammatory state.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1781937","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:25:25Z","timestamp":1773379525000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical analysis of 19 patients with tuberculosis complicated by hemophagocytic lymphohistiocytosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Chun-Yan","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Tuberculosis, The Fourth People\u2019s Hospital of Nanning","place":["Nanning, China"]},{"name":"Clinical Medical School, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, The Fourth People\u2019s Hospital of Nanning","place":["Nanning, China"]},{"name":"Clinical Medical School, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Dong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, The Fourth People\u2019s Hospital of Nanning","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Chun","family":"Huang","sequence":"additional","affiliation":[{"name":"Clinical Medical School, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuo","family":"Lao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, People\u2019s Hospital of Baise City","place":["Baise, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Wen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, The Fourth People\u2019s Hospital of Nanning","place":["Nanning, China"]},{"name":"Clinical Medical School, Guangxi Medical University","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou-Hua","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, The Fourth People\u2019s Hospital of Nanning","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Qing","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Tuberculosis, The Fourth People\u2019s Hospital of Nanning","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"B1","volume-title":"Global Tuberculosis Report 2025","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-093019-010426","article-title":"The innate immune response to Mycobacterium tuberculosis infection","volume":"39","author":"Ravesloot-Ch\u00e1vez","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"Hlh-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1586\/eci.09.58","article-title":"Primary and secondary hemophagocytic lymphohistiocytosis: Clinical features, pathogenesis and therapy","volume":"6","author":"Gupta","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1186\/s12879-024-10220-7","article-title":"Comprehensive insights into tuberculosis-associated hemophagocytic lymphohistiocytosis: A systematic review","volume":"24","author":"Eslami","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4103\/0970-2113.168100","article-title":"Hemophagocytic lymphohistiocytosis: An unusual complication in disseminated Mycobacterium tuberculosis","volume":"32","author":"Padhi","year":"2015","journal-title":"Lung India"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.3390\/jcm12165366","article-title":"Tuberculosis-associated hemophagocytic lymphohistiocytosis: A review of current literature","volume":"12","author":"Fauchald","year":"2023","journal-title":"J Clin Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20220310-00488","article-title":"Diagnosis and treatment guidelines for hemophagocytic syndrome in China (2022 edition)","volume":"102","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad697","article-title":"Tuberculosis-associated hemophagocytic lymphohistiocytosis: Diagnostic challenges and determinants of outcome","volume":"11","author":"Kurver","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1210041","article-title":"Approaching hemophagocytic lymphohistiocytosis","volume":"14","author":"Chinnici","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac717","article-title":"Severe mycobacterial immune reconstitution inflammatory syndrome (Iris) in advanced human immunodeficiency virus (Hiv) has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression","volume":"76","author":"Rocco","year":"2023","journal-title":"Clin Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad059","article-title":"Mycobacterial immune reconstitution inflammatory syndrome in Hiv is associated with protein-altering variants in hemophagocytic lymphohistiocytosis-related genes","volume":"228","author":"Rocco","year":"2023","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.01.030","article-title":"Interleukin 12 (Il-12) family cytokines: Role in immune pathogenesis and treatment of Cns autoimmune disease","volume":"75","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053420","article-title":"The immune response to Mycobacterium tuberculosis in Hiv-1-coinfected persons","volume":"36","author":"Esmail","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(06)70524-2","article-title":"Tuberculosis-associated haemophagocytic syndrome","volume":"6","author":"Brastianos","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000936","article-title":"Pediatric hemophagocytic lymphohistiocytosis","volume":"135","author":"Canna","year":"2020","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (Hlh) and related disorders","author":"Filipovich","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-59815-9_30","article-title":"Cytokine storm and sepsis-induced multiple organ dysfunction syndrome","volume":"1448","author":"Carcillo","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (Hlh): Cd8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2007.08.001","article-title":"Fever of unknown origin caused by tuberculosis","volume":"21","author":"Bofinger","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.156246","article-title":"Miliary tuberculosis disease complicated by Pott's abscess in an infant: Seven year follow-up","volume":"32","author":"Bayhan","year":"2015","journal-title":"Lung India"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0811","article-title":"Diagnostic and prognostic value of serum C-reactive protein for screening for Hiv-associated tuberculosis","volume":"17","author":"Lawn","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0119-x","article-title":"Tuberculous meningitis: A roadmap for advancing basic and translational research","volume":"19","author":"Jain","year":"2018","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/ms9.0000000000003348","article-title":"Advances in management and treatment of tubercular meningitis - a narrative review","volume":"87","author":"Malik","year":"2025","journal-title":"Ann Med Surg (2012)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2024.2401352","article-title":"The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies","volume":"43","author":"Heidari-Foroozan","year":"2024","journal-title":"Int Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000030412","article-title":"The treatment effect of levofloxacin, moxifloxacin, and gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis","volume":"101","author":"He","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.10.001","article-title":"Hemophagocytic lymphohistiocytosis (Hlh): A heterogeneous spectrum of cytokine-driven immune disorders","volume":"26","author":"Brisse","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:25:26Z","timestamp":1773379526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1781937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1781937"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1781937","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"article-number":"1781937"}}